188 related articles for article (PubMed ID: 10097067)
21. Specific inhibition of the rat ligand-gated ion channel P2X3 function via methoxyethoxy-modified phosphorothioated antisense oligonucleotides.
Dorn G; Abdel'Al S; Natt FJ; Weiler J; Hall J; Meigel I; Mosbacher J; Wishart W
Antisense Nucleic Acid Drug Dev; 2001 Jun; 11(3):165-74. PubMed ID: 11446592
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of C-5 propynyl pyrimidine-containing oligonucleotides in vitro and in vivo.
Shen L; Siwkowski A; Wancewicz EV; Lesnik E; Butler M; Witchell D; Vasquez G; Ross B; Acevedo O; Inamati G; Sasmor H; Manoharan M; Monia BP
Antisense Nucleic Acid Drug Dev; 2003; 13(3):129-42. PubMed ID: 12954113
[TBL] [Abstract][Full Text] [Related]
23. Synergistic antitumor effect of chemotherapy and antisense-mediated ablation of the cell cycle inhibitor p27KIP-1.
Achenbach TV; Müller R; Slater EP
Clin Cancer Res; 2000 Aug; 6(8):3006-14. PubMed ID: 10955778
[TBL] [Abstract][Full Text] [Related]
24. Activation of the human p27(Kip1) promoter by IFNalpha 2b.
Moro A; Santos A; Araña MJ; Perea SE
Biochem Biophys Res Commun; 2000 Mar; 269(1):31-4. PubMed ID: 10694472
[TBL] [Abstract][Full Text] [Related]
25. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells.
Rivard N; Boucher MJ; Asselin C; L'Allemain G
Am J Physiol; 1999 Oct; 277(4):C652-64. PubMed ID: 10516095
[TBL] [Abstract][Full Text] [Related]
26. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1).
Wang G; Miskimins R; Miskimins WK
Exp Cell Res; 2000 Jan; 254(1):64-71. PubMed ID: 10623466
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression.
Monia BP; Lesnik EA; Gonzalez C; Lima WF; McGee D; Guinosso CJ; Kawasaki AM; Cook PD; Freier SM
J Biol Chem; 1993 Jul; 268(19):14514-22. PubMed ID: 8390996
[TBL] [Abstract][Full Text] [Related]
28. Effects of base modifications on antisense properties of 2'-O-methoxyethyl and PNA oligonucleotides.
Sazani P; Astriab-Fischer A; Kole R
Antisense Nucleic Acid Drug Dev; 2003; 13(3):119-28. PubMed ID: 12954112
[TBL] [Abstract][Full Text] [Related]
29. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
[TBL] [Abstract][Full Text] [Related]
30. Design of antisense and triplex-forming oligonucleotides.
François JC; Lacoste J; Lacroix L; Mergny JL
Methods Enzymol; 2000; 313():74-95. PubMed ID: 10595350
[No Abstract] [Full Text] [Related]
31. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells.
Wu M; Bellas RE; Shen J; Yang W; Sonenshein GE
J Immunol; 1999 Dec; 163(12):6530-5. PubMed ID: 10586045
[TBL] [Abstract][Full Text] [Related]
32. Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1).
Morimoto M; Nishida T; Honda R; Yasuda H
Biochem Biophys Res Commun; 2000 Apr; 270(3):1093-6. PubMed ID: 10772955
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
Lin R; Wang TT; Miller WH; White JH
Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
[TBL] [Abstract][Full Text] [Related]
34. Application of secondary structure prediction in antisense drug design targeting protein kinase C-alpha mRNA and QSAR analysis.
Song HF; Tang ZM; Yuan SJ; Zhu BZ
Acta Pharmacol Sin; 2000 Jan; 21(1):80-6. PubMed ID: 11263253
[TBL] [Abstract][Full Text] [Related]
35. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
de Koning JP; Soede-Bobok AA; Ward AC; Schelen AM; Antonissen C; van Leeuwen D; Löwenberg B; Touw IP
Oncogene; 2000 Jul; 19(29):3290-8. PubMed ID: 10918585
[TBL] [Abstract][Full Text] [Related]
36. Translation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotides.
Hasselblatt P; Hockenjos B; Thoma C; Blum HE; Offensperger WB
Nucleic Acids Res; 2005; 33(1):114-25. PubMed ID: 15640448
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of C-raf expression by antisense oligonucleotides extends heart allograft survival in rats.
Stepkowski SM; Qu X; Wang ME; Tian L; Chen W; Wancewicz EV; Johnston JF; Bennett CF; Monia BP
Transplantation; 2000 Aug; 70(4):656-61. PubMed ID: 10972225
[TBL] [Abstract][Full Text] [Related]
38. Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA.
Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
Biophys J; 2002 Jan; 82(1 Pt 1):366-77. PubMed ID: 11751323
[TBL] [Abstract][Full Text] [Related]
39. Low levels of cyclin D and nonfunctional Rb protein affect cdk6 association with cyclin-dependent kinase inhibitor p27(Kip1).
Kwon TK; Park JW
Biochem Biophys Res Commun; 2001 Jun; 284(1):106-11. PubMed ID: 11374878
[TBL] [Abstract][Full Text] [Related]
40. Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA.
Seibold S; Schürle D; Heinloth A; Wolf G; Wagner M; Galle J
J Am Soc Nephrol; 2004 Dec; 15(12):3026-34. PubMed ID: 15579505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
